Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002328655 | SCV002635393 | pathogenic | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2020-03-31 | criteria provided, single submitter | clinical testing | The c.4498dupT pathogenic mutation, located in coding exon 33 of the NF1 gene, results from a duplication of T at nucleotide position 4498, causing a translational frameshift with a predicted alternate stop codon (p.Y1500Lfs*9). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Institute of Medical Genetics and Applied Genomics, |
RCV003445170 | SCV004174167 | pathogenic | Neurofibromatosis, type 1 | 2023-12-06 | criteria provided, single submitter | clinical testing |